Search clinical trials for: erectile dysfunction, PDE-5 inhibitor

Total 77992 results

Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine for the Treatment of Generalized Anxiety Disorder

Generalized Anxiety Disorder

China
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
Eli Lilly and Company

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Taiwan
Eli Lilly and Company

Completed

Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients

Non Small Cell Lung Cancer

France
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Major Depressive Disorder

United States, France, Mexico, Puerto Rico
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)

Acute Coronary Syndrome

France
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers

Benign Prostatic Hyperplasia

United States, Puerto Rico
Eli Lilly and Company

Completed

Switching to Duloxetine in Patients With Depression (ARDENT)

Depressive Disorder, Major

Korea, Republic of
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia

Fibromyalgia

United States, Puerto Rico
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression (TRY FIRST)

Depression

United States
Eli Lilly and Company

Completed

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Attention Deficit Hyperactivity Disorder | Reading Disorder

Belgium, Netherlands
Eli Lilly and Company

Completed

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Autistic Disorder | Attention Deficit Disorder With Hyperactivity

Netherlands
Eli Lilly and Company

Completed

Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

Attention Deficit Hyperactivity Disorder

United States, Puerto Rico
Eli Lilly and Company

Completed

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Attention Deficit Hyperactivity Disorder | Oppositional Defiant Disorder

Germany
Eli Lilly and Company

Completed

Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain
Eli Lilly and Company

Completed

Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Korea, Republic of
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in Chronic Low Back Pain

Back Pain Without Radiation

United States
Eli Lilly and Company
Gynecologic Oncology Group

Completed

A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cancer

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients

Breast Cancer

Austria, Czech Republic, Hungary, Poland, Romania, Russian Federation
Eli Lilly and Company

Completed

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States, China, Italy, Australia, Spain, Germany, Belgium, United Kingdom, Hungary, Taiwan, Austria, France, Poland, Greece, Netherlands, Brazil, India, Romania, Turkey, Russian Federation, Argentina, South Africa, Korea, Republic... and more
Eli Lilly and Company

Completed

Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer

Neoplasm, Gastric

Taiwan, Argentina, Mexico, Korea, Republic of
Eli Lilly and Company
i3 Drug Safety

Completed

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Transient Ischemic Attack | ADHD | Cerebrovascular Accident

United States
Eli Lilly and Company

Completed

Treatment Compliance in Children and Adolescents on ADHD Medication (COMPLY)

ADHD

Germany
Eli Lilly and Company

Completed

Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer

Metastatic Breast Cancer

China
Eli Lilly and Company

Terminated

Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

Non-Small-Cell Lung Cancer

Spain
Eli Lilly and Company

Completed

Gemcitabine in Ovarian Cancer

Ovarian Cancer

Russian Federation
Eli Lilly and Company

Completed

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Attention Deficit Hyperactivity Disorder | Oppositional Defiant Disorder

Australia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
Eli Lilly and Company

Terminated

A Study in the Treatment of Acute Mania

Bipolar Disorder

Sweden
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

Gastroparesis

Canada
Eli Lilly and Company

Completed

A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

Liver Cancer

United States
Eli Lilly and Company

Completed

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

ADHD

United States
Eli Lilly and Company

Completed

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Urologic Neoplasms | Carcinoma, Transitional Cell

Japan
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Anxiety Disorders

United States, Finland, France, Germany, South Africa, Spain, Sweden
Eli Lilly and Company

Completed

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

Attention Deficit Hyperactivity Disorder

Canada, United States
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil in Subjects With Mild to Moderate Hypertension

Hypertension

United States
Eli Lilly and Company

Completed

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Spain
Eli Lilly and Company

Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Slovakia
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

Schizophrenic Disorders

Turkey, Finland
Eli Lilly and Company

Completed

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

Non-Small Cell Lung Cancer

China
Eli Lilly and Company

Completed

Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer

Breast Cancer

Argentina, Belgium, Germany, Romania, Spain, United Kingdom
Eli Lilly and Company

Completed

Duloxetine Versus Placebo for Fibromyalgia

Fibromyalgia

United States
Eli Lilly and Company

Completed

Weight Gain Management in Patients With Schizophrenia

Schizophrenia

Brazil
Eli Lilly and Company

Completed

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Schizophrenic Disorders

Korea, Republic of
Eli Lilly and Company

Completed

Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Combination Therapy in Patients With Depression

Depressive Symptoms

United States
Eli Lilly and Company

Completed

Evaluation of the Effects of Duloxetine on Norepinephrine

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Urge Incontinence Bladder Overactivity Study

Urinary Incontinence

United States, Australia, Canada

Search clinical trials for: erectile dysfunction, PDE-5 inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations